TP53 and colorectal carcinoma: Furthermore, numerous studies have demonstrated the involvement of secondary bile acids in the pathogenesis of CRC, including promoting cell proliferation [41], inhibiting apoptosis of CRC cells [42], promoting P53 degradation [43] and increasing cell aggressiveness [44].